GSK3 inhibitors are interesting, but we don't understand much the subtypes that are likely to exist: "GSK-3 appears to both promote and inhibit apoptosis, and t

GSK3 inhibitors are interesting, but we don't understand much the subtypes that are likely to exist: "GSK-3 appears to both promote and inhibit apoptosis, and this regulation varies depending on the specific molecular and cellular context." Still, I believe better GSK3i will find a role in autologous bone-marrow grafting therapies to fight senescence: with TERC/TERT overexpression (the opposite of DeGrey WILT ideas) to send new stem cells to the tissues - just like how you can find the donors chromosomes in most tissues of grafted patient.